GoldPoint Clinical Research is a national clinical trial research center for central nervous system disorders. The company tests new drug treatments for depression, Alzheimer’s disease, generalized anxiety disorder, ADHD, bipolar disorder, fibromyalgia, OCD, PTSD and schizophrenia, among other disorders.
Synergy conducted marketing research and strategic marketing planning to evolve GoldPoint’s brand identity to establish credibility and appeal to both industry (pharmaceutical companies and CROs) and a wide spectrum of patient populations. The agency also created a new website and social media strategy designed to capture organic Internet traffic searching for diagnoses, alternative healthcare and medical treatment options for a variety of mental health, psychological and neurological conditions. The new website and digital marketing efforts enabled GoldPoint to promote active clinical trials, target niche and localized patient populations and build a continually growing database of patients across nearly a dozen diseases.
If you need help marketing clinical trials, medical research programs or recruiting patients for specific diseases or in targeted geographic markets, please contact us. We have extensive experience in the industry and we’ve earned a reputation as one of the most accomplished clinical trials marketing agencies.